ALZHEIMER KASALLIGINI ANIQLASH VA DAVOLASHDAGI YANGI YONDASHUVLAR
Ключевые слова:
Alzheimer kasalligi, erta aniqlash, miya tasvirlash, biomarkerlarga asoslangan diagnostika, sun'iy intellekt, amyloid beta, tau oqsillari, dori terapiyasi, gen terapiyasi, neurostimulatsiya.Аннотация
Alzheimer kasalligi markaziy nerv tizimining degenerativ kasalligi bo‘lib, asosan xotira va fikrlash qobiliyatini buzadi. Ushbu maqolada Alzheimer kasalligini erta aniqlash va davolashdagi yangi yondashuvlar, jumladan miya tasvirlash texnologiyalari, biomarkerlarga asoslangan diagnostika, sun'iy intellekt va gen terapiyasi muhokama qilinadi. Kasallikning rivojlanishini sekinlashtirish va
bemorlarning hayot sifatini yaxshilashga qaratilgan texnologiyalar va innovatsiyalarni ko‘rib chiqiladi.
Библиографические ссылки
1.
Sperling, R. A., Aisen, P. S., Beckett, L. A., et al. (2011). "Toward defining the
preclinical stages of Alzheimer's disease: Recommendations from the National
Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for
Alzheimer's disease." Alzheimer's & Dementia, 7(3), 280-292.
2.
Jack, C. R., Bennett, D. A., Blennow, K., et al. (2018). "NIA-AA Research
Framework: Toward a biological definition of Alzheimer's disease." Alzheimer's &
Dementia, 14(4), 535-562.
3.
Aisen, P. S., Cummings, J., & Jack, C. R. (2017). "On the path to 2025:
Understanding the Alzheimer's disease continuum." Alzheimer's & Dementia, 13(4),
267-276.
4.
Hampel, H., O'Bryant, S. E., Boada, M., et al. (2018). "Blood-based biomarkers
for Alzheimer's disease: The role of biomarkers in early diagnosis." Alzheimer's &
Dementia, 14(7), 807-818.
5.
DeTure, M. A., & Dickson, D. W. (2019). "The neuropathological diagnosis of
Alzheimer's disease." Molecular Neurodegeneration, 14(1), 32.
6.
Maxamatjanova, N., & Djalilova, S. (2017, January). The significance of
neurovisualization
psycho-emotional
disorders
in
cerebral
In
CEREBROVASCULAR DISEASES (Vol. 43). ALLSCHWILERSTRASSE 10, CH
4009 BASEL, SWITZERLAND: KARGER 7.
Mosconi, L. (2018). "Brain imaging in Alzheimer's disease and the use of
biomarkers." Neuroimaging Clinics of North America, 28(3), 381-398.
8.
Tariot, P. N., & Vellas, B. (2018). "New treatment approaches for Alzheimer's
disease." The Lancet Neurology, 17(4), 326-336.
9.
Hardy, J., & Selkoe, D. J. (2002). "The amyloid hypothesis of Alzheimer's
disease: Progress and problems on the road to therapeutics." Science, 297(5580), 353
356.
10. Dubois, B., Hampel, H., & Feldman, H. H. (2016). "Preclinical Alzheimer's
disease: Definition, natural history, and diagnostic criteria." Alzheimer's & Dementia,
12(3), 292-298.
11. Jessen, F., & Scheef, L. (2015). "Functional neuroimaging in Alzheimer's
disease." Psychiatry Research: Neuroimaging, 223(1), 1-11
12. https://www.demokrat.uz/2023/12/31/altsgeymer-kasalligini-eksperimental
davolash-ishlab-chiqildi
13. https://caravan-info.uz/uz/novosti/402672-avstraliyskie-uchenye-razrabotali
preparat-sposobnyy-ostanovit-dementsiyu-na-rannih-stadiyah
14.
15.
16.
